Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers
Authors:
Open Access
- 1 November 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (47) , e8802
Abstract
The effect of chronic metabolic acidosis (MA) on cardiovascular disease (CVD) in the setting of chronic kidney disease (CKD) is largely unknown. Therefore, we aimed to study this relationship in nondialysis CKD patients. This cross-sectional, single-center study prospectively enrolled 95 clinically stable CKD patients (median age 61 (58, 65) years, 60% male, median eGFR 27 (22, 32) mL/min). Data on CKD etiology, CVD history, CVD traditional, and nontraditional risk factors were obtained. Also, markers of subclinical CVD were assessed: intima-media thickness (IMT), abdominal aortic calcifications (Kauppila score—AACs), cardio-ankle vascular index (CAVI), ankle-brachial index (ABI), ejection fraction, and interventricular septum thickness. Using the serum bicarbonate cutoff value of 22 mEq/L, comparisons between MA (P < .01), higher iPTH (P = .01), higher serum phosphate (P < .01), and increased serum cholesterol (P = .04) and triglycerides (P = .01). Higher ABI (P = .04), lower IMT (P = .03), CAVI (P = .05), and AACs (P = .03) were found in patients with chronic MA. Separate binomial logistic regression models were performed using ABI (cutoff 0.9), CAVI (cutoff 9), IMT (cutoff 0.1 cm), and AACs (cutoff 1) as dependent variables. MA was used as independent variable and adjustments were made for iPTH, serum phosphate, eGFR, proteinuria, cholesterol, triglycerides, CVD score. The absence of MA was retained as an independent predictor only for the presence of AACs. In conclusion, the present study shows a potential advantageous effect of MA on vascular calcifications in predialysis CKD patients. Thus, a guideline relaxation of the serum bicarbonate target might prove to be beneficial in CKD patients at high risk of vascular calcifications. However, one should always consider the negative effects of MA. Therefore, additional research is warranted before any clear clinical recommendation.Keywords
This publication has 52 references indexed in Scilit:
- Association of Serum Bicarbonate With Risk of Renal and Cardiovascular Outcomes in CKD: A Report From the Chronic Renal Insufficiency Cohort (CRIC) StudyAmerican Journal of Kidney Diseases, 2013
- High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patientsBMC Nephrology, 2013
- Ankle--brachial index, vascular calcifications and mortality in dialysis patientsNephrology Dialysis Transplantation, 2011
- Diet-Dependent Net Acid Load and Risk of Incident Hypertension in United States WomenHypertension, 2009
- Association of Chronic Kidney Disease With the Spectrum of Ankle Brachial IndexJACC, 2009
- Vascular CalcificationJournal of the American Society of Nephrology, 2009
- Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKDJournal of the American Society of Nephrology, 2009
- Calciphylaxis: Natural history, risk factor analysis, and outcomeJournal of the American Academy of Dermatology, 2007
- Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney diseaseHeart, 2006
- Cardiovascular Mortality Risk in Chronic Kidney DiseaseJAMA, 2005